DK3058374T3 - Fremgangsmåde til diagnose af primær hyperaldosteronisme - Google Patents
Fremgangsmåde til diagnose af primær hyperaldosteronisme Download PDFInfo
- Publication number
- DK3058374T3 DK3058374T3 DK14789218.6T DK14789218T DK3058374T3 DK 3058374 T3 DK3058374 T3 DK 3058374T3 DK 14789218 T DK14789218 T DK 14789218T DK 3058374 T3 DK3058374 T3 DK 3058374T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- procedure
- primary hyperaldosteronism
- hyperaldosteronism
- primary
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
- G01N2410/02—Angiotensins; Related peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20130189386 EP2863228A1 (en) | 2013-10-18 | 2013-10-18 | Method for diagnosis of primary hyperaldosteronism |
EP14152763 | 2014-01-28 | ||
PCT/EP2014/072339 WO2015055825A1 (en) | 2013-10-18 | 2014-10-17 | Method for diagnosis of primary hyperaldosteronism |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3058374T3 true DK3058374T3 (da) | 2019-08-26 |
Family
ID=51794861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14789218.6T DK3058374T3 (da) | 2013-10-18 | 2014-10-17 | Fremgangsmåde til diagnose af primær hyperaldosteronisme |
Country Status (13)
Country | Link |
---|---|
US (2) | US9829496B2 (da) |
EP (1) | EP3058374B1 (da) |
JP (1) | JP6397907B2 (da) |
CN (1) | CN105683760A (da) |
AU (1) | AU2014336122B2 (da) |
BR (1) | BR112016007960B8 (da) |
CA (1) | CA2926382C (da) |
DK (1) | DK3058374T3 (da) |
EA (1) | EA035289B1 (da) |
ES (1) | ES2745099T3 (da) |
HU (1) | HUE045337T2 (da) |
PL (1) | PL3058374T3 (da) |
WO (1) | WO2015055825A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10559377B2 (en) | 2013-01-09 | 2020-02-11 | Biomed Concepts Inc. | Graphical user interface for identifying diagnostic and therapeutic options for medical conditions using electronic health records |
US9829496B2 (en) * | 2013-10-18 | 2017-11-28 | Attoquant Diagnostics Gmbh | Method for diagnosis of primary hyperaldosteronism |
WO2017127459A1 (en) * | 2016-01-19 | 2017-07-27 | Biomed Concepts Inc. | Method and system for identifying diagnostic and therapeutic options for medical conditions using electronic health records |
WO2018094125A1 (en) * | 2016-11-17 | 2018-05-24 | Laboratory Corporation Of America Holdings | Methods and systems for measuring plasma renin activity |
CN106770824A (zh) * | 2016-12-21 | 2017-05-31 | 河南出入境检验检疫局检验检疫技术中心 | 利用高分辨质谱仪检测血浆中痕量醛固酮的方法 |
JP7067758B2 (ja) * | 2017-06-30 | 2022-05-16 | 国立大学法人 新潟大学 | 試料中のアンジオテンシンペプチドの量を測定するための方法及びアンジオテンシンペプチドの定量キット |
CN112037931B (zh) * | 2020-07-15 | 2023-10-20 | 新疆维吾尔自治区人民医院 | 在疑似原发性醛固酮增多症中应用的醛固酮增多预测体系 |
CN112014509A (zh) * | 2020-09-03 | 2020-12-01 | 复旦大学附属中山医院 | 同步测定样品中血管紧张素i和醛固酮的方法 |
CN113533552B (zh) * | 2021-06-02 | 2023-08-29 | 杭州凯莱谱精准医疗检测技术有限公司 | 液相色谱串联质谱检测肾素活性过程中对影响arr药物同步检测的方法 |
CN117554603B (zh) * | 2023-11-28 | 2024-05-10 | 中国医学科学院阜外医院 | 一种用于原发性醛固酮增多症初筛的标志物组合及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3919407A (en) * | 1973-11-28 | 1975-11-11 | De Castro Aurora L Fernandez | Method for quantitative determination of renin activity in blood |
JPH022935A (ja) * | 1988-06-20 | 1990-01-08 | Tosoh Corp | アンジオテンシンの測定法 |
US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
AU2002304965A1 (en) * | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
WO2007109733A2 (en) * | 2006-03-21 | 2007-09-27 | The Johns Hopkins University | Diagnostic and prognostic markers and treatment strategies for multiple sclerosis |
NZ571820A (en) * | 2006-05-29 | 2010-09-30 | Nicox Sa | Nitrated heterocyclic compounds as endothelin receptor antagonist |
WO2008103420A1 (en) * | 2007-02-21 | 2008-08-28 | The Regents Of The University Of Michigan | Compositions and methods for tranquilizing heart muscle |
EP2225559B8 (en) * | 2007-12-28 | 2016-12-21 | F. Hoffmann-La Roche AG | Assessment of physiological conditions |
AU2013230886B2 (en) * | 2012-03-08 | 2015-10-01 | Medtronic Af Luxembourg S.A.R.L. | Renal neuromodulation methods and systems for treatment of hyperaldosteronism |
CN102586223A (zh) * | 2012-03-08 | 2012-07-18 | 南京大学 | 一种基于mypt1基因敲除建立新型高血压小鼠模型的方法及其用途 |
US9829496B2 (en) * | 2013-10-18 | 2017-11-28 | Attoquant Diagnostics Gmbh | Method for diagnosis of primary hyperaldosteronism |
-
2014
- 2014-10-17 US US15/030,339 patent/US9829496B2/en active Active
- 2014-10-17 WO PCT/EP2014/072339 patent/WO2015055825A1/en active Application Filing
- 2014-10-17 CA CA2926382A patent/CA2926382C/en active Active
- 2014-10-17 ES ES14789218T patent/ES2745099T3/es active Active
- 2014-10-17 BR BR112016007960A patent/BR112016007960B8/pt active Search and Examination
- 2014-10-17 PL PL14789218T patent/PL3058374T3/pl unknown
- 2014-10-17 HU HUE14789218A patent/HUE045337T2/hu unknown
- 2014-10-17 JP JP2016524104A patent/JP6397907B2/ja active Active
- 2014-10-17 AU AU2014336122A patent/AU2014336122B2/en active Active
- 2014-10-17 EP EP14789218.6A patent/EP3058374B1/en active Active
- 2014-10-17 DK DK14789218.6T patent/DK3058374T3/da active
- 2014-10-17 EA EA201690796A patent/EA035289B1/ru not_active IP Right Cessation
- 2014-10-17 CN CN201480057185.8A patent/CN105683760A/zh active Pending
-
2017
- 2017-10-20 US US15/789,433 patent/US10295552B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PL3058374T3 (pl) | 2020-02-28 |
US9829496B2 (en) | 2017-11-28 |
EP3058374A1 (en) | 2016-08-24 |
BR112016007960B8 (pt) | 2023-11-14 |
JP6397907B2 (ja) | 2018-09-26 |
US10295552B2 (en) | 2019-05-21 |
EA201690796A1 (ru) | 2016-08-31 |
US20160266151A1 (en) | 2016-09-15 |
AU2014336122B2 (en) | 2020-06-25 |
US20180164330A1 (en) | 2018-06-14 |
WO2015055825A1 (en) | 2015-04-23 |
AU2014336122A1 (en) | 2016-04-07 |
NZ717888A (en) | 2022-03-25 |
EA035289B1 (ru) | 2020-05-25 |
BR112016007960A8 (pt) | 2020-03-17 |
BR112016007960B1 (pt) | 2023-03-07 |
ES2745099T3 (es) | 2020-02-27 |
CN105683760A (zh) | 2016-06-15 |
JP2017500538A (ja) | 2017-01-05 |
CA2926382C (en) | 2020-06-02 |
CA2926382A1 (en) | 2015-04-23 |
HUE045337T2 (hu) | 2019-12-30 |
EP3058374B1 (en) | 2019-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3058374T3 (da) | Fremgangsmåde til diagnose af primær hyperaldosteronisme | |
DK3076967T3 (da) | Fremgangsmåder til behandling af residuelle symptomer på skizofreni | |
DK3227804T3 (da) | Forhåndsdiagnose af funktionsevne for infusionsanordnings driftsmodus | |
DK3611262T3 (da) | Fremgangsmåder til sekvensering af immunrepertoire | |
DK3006568T3 (da) | Fremgangsmåde til fremstilling af tagatose | |
DK3083540T3 (da) | Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner | |
DK3117030T3 (da) | Diagnosticering af sepsis | |
DK3020727T4 (da) | Mutant calreticulin til diagnose af myeloide maligniteter | |
DK2972353T3 (da) | Forbedrede fremgangsmåder til udførelse af multipleksanalyser | |
DK2970951T3 (da) | Fremgangsmåder til nukleinsyresekventering | |
DK3940352T3 (da) | Fremgangsmåde til diagnosticering af vægte | |
DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
DK3007726T3 (da) | Fremgangsmåder til behandling af en tauopati | |
DK3041349T3 (da) | Anordning til angrebsdiagnose | |
DK3005298T3 (da) | Fremgangsmåde til rekonstruktion af et objekt fra projektionsafbildninger | |
DK3068359T3 (da) | Indikator for hældningen af sengen | |
DK2969098T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
DK3071670T3 (da) | Integreret fremgangsmåde til fremstilling af carbonhydrider | |
DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
DK2836460T3 (da) | Fremgangsmåde til fremstilling af graphen | |
DK2988659T3 (da) | Forbedrede fremgangsmåder til vævskarakterisering | |
DK2991543T3 (da) | System til visualisering af kropsområder | |
DK2908724T3 (da) | Fremgangsmåde til at følge udviklingen af en hjernelæsion | |
DK2985275T3 (da) | Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre | |
FI20135397A (fi) | Testausadapteri |